Literature DB >> 27577612

Behavioral effects of chronically elevated corticosterone in subregions of the medial prefrontal cortex.

Joshua D Croteau1, Jay Schulkin2, Jack D Shepard3.   

Abstract

The medial prefrontal cortex is a key mediator of behavioral aspects of the defense response. Since chronic exposure to elevated glucocorticoids alters the dendritic structure of neurons in the medial prefrontal cortex, such exposure may alter behavioral responses to danger as well. We examined the effects of chronically elevated corticosterone in discrete regions of the medial prefrontal cortex on exploration of the elevated plus-maze. Chronically elevated corticosterone in the prelimbic or infralimbic cortices reduced open arm exploration. This effect was specific to the ventral regions of the medial prefrontal cortex as corticosterone had no effect on plus-maze exploration when administered into the anterior cingulate cortex. Taken together, these findings demonstrate clear regional differences for the effects of corticosterone in the medial prefrontal cortex.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anxiety; Cingulate; Corticosterone; Fear; Glucocorticoids; Infralimbic; Prefrontal cortex; Prelimbic

Mesh:

Substances:

Year:  2016        PMID: 27577612      PMCID: PMC5051954          DOI: 10.1016/j.bbr.2016.08.055

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  26 in total

1.  Corticosterone implants to the amygdala and type 1 CRH receptor regulation: effects on behavior and colonic sensitivity.

Authors:  Dean A Myers; Matthew Gibson; Jay Schulkin; Beverley Greenwood Van-Meerveld
Journal:  Behav Brain Res       Date:  2005-04-22       Impact factor: 3.332

2.  Efferent projections of the infralimbic (area 25) region of the medial prefrontal cortex in the rat: an anterograde tracer PHA-L study.

Authors:  M Takagishi; T Chiba
Journal:  Brain Res       Date:  1991-12-06       Impact factor: 3.252

Review 3.  Coming to terms with fear.

Authors:  Joseph E LeDoux
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-05       Impact factor: 11.205

Review 4.  From normal fear to pathological anxiety.

Authors:  J B Rosen; J Schulkin
Journal:  Psychol Rev       Date:  1998-04       Impact factor: 8.934

5.  Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration.

Authors:  C L Wellman
Journal:  J Neurobiol       Date:  2001-11-15

6.  Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior.

Authors:  J D Shepard; K W Barron; D A Myers
Journal:  Brain Res       Date:  2000-04-10       Impact factor: 3.252

7.  Specific configuration of dendritic degeneration in pyramidal neurons of the medial prefrontal cortex induced by differing corticosteroid regimens.

Authors:  João J Cerqueira; Ricardo Taipa; Harry B M Uylings; Osborne F X Almeida; Nuno Sousa
Journal:  Cereb Cortex       Date:  2006-11-02       Impact factor: 5.357

8.  Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Authors:  S Pellow; P Chopin; S E File; M Briley
Journal:  J Neurosci Methods       Date:  1985-08       Impact factor: 2.390

9.  The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress.

Authors:  D Diorio; V Viau; M J Meaney
Journal:  J Neurosci       Date:  1993-09       Impact factor: 6.167

10.  Stereotaxic localization of corticosterone to the amygdala enhances hypothalamo-pituitary-adrenal responses to behavioral stress.

Authors:  Jack D Shepard; Kirk W Barron; Dean A Myers
Journal:  Brain Res       Date:  2003-02-14       Impact factor: 3.252

View more
  1 in total

1.  Maternal separation blunted spatial memory formation independent of peripheral and hippocampal insulin content in young adult male rats.

Authors:  Soheila Maghami; Homeira Zardooz; Fariba Khodagholi; Fatemeh Binayi; Roya Ranjbar Saber; Mehdi Hedayati; Hedayat Sahraei; Mohammad Ali Ansari
Journal:  PLoS One       Date:  2018-10-17       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.